APA

Tichmann I., Preidel H., Grunert D., Habash S., Schult R., Maier R., Gildberg P. K., Sengespeik H., Meurice F. & Sänger R. (20050613). Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age. : Vaccine.

Chicago

Tichmann I, Preidel H, Grunert D, Habash S, Schult R, Maier R, Gildberg P K, Sengespeik H-C, Meurice F and Sänger R. 20050613. Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age. : Vaccine.

Harvard

Tichmann I., Preidel H., Grunert D., Habash S., Schult R., Maier R., Gildberg P. K., Sengespeik H., Meurice F. and Sänger R. (20050613). Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age. : Vaccine.

MLA

Tichmann I, Preidel H, Grunert D, Habash S, Schult R, Maier R, Gildberg P K, Sengespeik H-C, Meurice F and Sänger R. Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age. : Vaccine. 20050613.